These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 39576827)

  • 1. CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells.
    Pellegrino B; David K; Rabani S; Lampert B; Tran T; Doherty E; Piecychna M; Meza-Romero R; Leng L; Hershkovitz D; Vandenbark AA; Bucala R; Becker-Herman S; Shachar I
    PLoS Biol; 2024 Nov; 22(11):e3002905. PubMed ID: 39576827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer.
    Rabani S; Gunes EG; Gunes M; Pellegrino B; Lampert B; David K; Pillai R; Li A; Becker-Herman S; Rosen ST; Shachar I
    Cell Rep; 2024 Nov; 43(11):114920. PubMed ID: 39466774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.
    Ryan R; Hill S
    Cochrane Database Syst Rev; 2019 Oct; 10(10):ED000141. PubMed ID: 31643081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlocking data: Decision-maker perspectives on cross-sectoral data sharing and linkage as part of a whole-systems approach to public health policy and practice.
    Tweed E; Cimova K; Craig P; Allik M; Brown D; Campbell M; Henderson D; Mayor C; Meier P; Watson N
    Public Health Res (Southampt); 2024 Nov; ():1-30. PubMed ID: 39582242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like receptor 3-mediated interferon-β production is suppressed by oncostatin m and a broader epithelial-mesenchymal transition program.
    Chernosky NM; Tamagno I; Polak KL; Chan ER; Yuan X; Jackson MW
    Breast Cancer Res; 2024 Nov; 26(1):167. PubMed ID: 39593161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression decreases immunity and PD-L1 inhibitor efficacy via the hypothalamic-pituitary-adrenal (HPA) axis in triple-negative breast cancer.
    Yu S; Gan C; Li W; Zhang Q; Cai Y; Xu J; Huang R; Yao S; Cheng L; Cheng H
    Biochim Biophys Acta Mol Basis Dis; 2025 Feb; 1871(2):167581. PubMed ID: 39579799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Blog-Based Study of Autistic Adults' Experiences of Aloneness and Connection and the Interplay with Well-Being: Corpus-Based and Thematic Analyses.
    Petty S; Allen S; Pickup H; Woodier B
    Autism Adulthood; 2023 Dec; 5(4):437-449. PubMed ID: 38116056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Surgical and Nonsurgical Aesthetic Procedures: A 14-Year Analysis of the International Society of Aesthetic Plastic Surgery-ISAPS.
    Triana L; Palacios Huatuco RM; Campilgio G; Liscano E
    Aesthetic Plast Surg; 2024 Oct; 48(20):4217-4227. PubMed ID: 39103642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gambogic acid impairs the maintenance and therapeutic resistance of glioma stem cells by targeting B-cell-specific Moloney leukemia virus insert site 1.
    Sun T; Lin B; Sun Q; Zhang X; Wang T; Yang J; Liu X; Lu H; Lu N; Zhao K
    Phytomedicine; 2024 Dec; 135():156070. PubMed ID: 39326139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XIAOPI formula inhibits chemoresistance and metastasis of triple-negative breast cancer by suppressing extracellular vesicle/CXCL1-induced TAM/PD-L1 signaling.
    Wang S; Xu S; Li J; Wang N; Zheng Y; Wang Z
    Phytomedicine; 2024 Dec; 135():156039. PubMed ID: 39303510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting antitumor immunity in breast cancers: Potential of adjuvants, drugs, and nanocarriers.
    Chen P; Ren L; Guo Y; Sun Y
    Int Rev Immunol; 2024 Nov; ():1-24. PubMed ID: 39611269
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.